DYCQ
DT Cloud Acquisition Corporation11.18
+0.00+0%
Nov 19, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
32.37MP/E (TTM)
44.72Basic EPS (TTM)
0.25Dividend Yield
0%Recent Filings
10-Q
Q3 FY2025 results
DT Cloud Acquisition posted a Q3 net loss of $242K versus $760K profit last year, driven by $163K non-redemption agreement expense atop routine formation costs, while trust dividend income fell to $89K from $918K (derived). Operating loss widened to $332K from $158K y/y, offset partly by other income, yielding $(0.09) diluted EPS on 779K redeemable shares. Trust shrank 98% to $1.6M after heavy redemptions, with cash at $0 but $715K promissory notes from target Maius and $400K sponsor due. Extensions secured to February 2027. Non-GAAP metrics not disclosed in the 10-Q. Trust holds steady.
8-K
Nasdaq delisting suspension imminent
DT Cloud Acquisition Corporation faces Nasdaq delisting after the exchange rejected its compliance plan on November 12, 2025, for failing the public shares requirement by wide margins. Trading in its ordinary shares halts November 21 unless appealed. Delisting looms. No assurance of Panel approval or regained compliance.
8-K
SPAC secures merger financing
DT Cloud Acquisition Corporation inked a subscription agreement on September 29, 2025, for an investor to buy 15,000 Pubco ordinary shares at $10.00 each in a private placement tied to its pending SPAC merger with Maius Pharmaceutical. This $150,000 infusion bolsters financing for the deal, yet the SPAC faces Nasdaq delisting pressure after its market value of publicly held shares dipped below $15 million for 30 days, granting until March 24, 2026, to rebound. Compliance hangs in the balance.
8-K
Nasdaq deficiency and extension approved
DT Cloud Acquisition Corporation received Nasdaq notices on August 22 and 25, 2025, for failing the $50 million minimum market value of listed securities and 1.1 million publicly held shares requirements, with no immediate delisting impact but 180 days to fix the market value issue. Shareholders approved extensions at an August 21 meeting, pushing the business combination deadline to February 23, 2027, and waiving monthly extension fees starting August 23, 2025. Yet 689,033 shares redeemed for $7.6 million, worsening the public shares deficiency. Compliance hangs in the balance.
10-Q
Q2 FY2025 results
DT Cloud Acquisition Corporation posted a net income of $234,657 for Q2 FY2025 ended June 30, 2025, down from $828,866 a year earlier, as formation and operating costs climbed to $269,124 from $78,470 while dividend income from the trust account fell to $503,781 from $907,328. Year-to-date through six months, net income reached $686,742, versus $872,741 last year, with costs doubling to $557,386 amid ongoing merger pursuits. The trust balance shrank to $9.1 million after redemptions totaling over 6 million shares across multiple extensions, leaving cash at zero but supported by $545,975 in interest-free promissory notes from the target and $368,127 due to the sponsor. No free cash flow is generated pre-combination. The proposed merger with Maius Pharmaceutical, valued at $250 million in Pubco shares, advanced with extensions to July 2025, yet regulatory hurdles from the China Securities Regulatory Commission pose a key risk.
AQUC
Aquaron Acquisition Corp.
12.10+0.00
DAAQ
Digital Asset Acquisition Corp.
10.17-0.01
DMYY
dMY Squared Technology Group, I
13.03+0.04
DTSQ
DT Cloud Star Acquisition Corpo
10.75-0.06
ETHM
Dynamix Corporation
10.40-0.05
QETA
Quetta Acquisition Corporation
11.20-0.05
TACH
Titan Acquisition Corp.
10.24-0.01
TDAC
Translational Development Acqui
10.42+0.00
UYSC
UY Scuti Acquisition Corp.
10.22+0.00
YOTA
Yotta Acquisition Corporation
2.00+0.00